Bush Tia L (CIK 1863418) reported 15 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-24). Recent activity: Sell CNTA (147,954 shares), Sell CNTA (8,549 shares), Buy CNTA (35,000 shares), Buy CNTA (40,000 shares), Sell CNTA (40,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-24 | Centessa Pharmaceuticals plc (CNTA) | Chief Technology & Quality Ofc | Sell | 147,954 | $0 |
| 2026-02-03 | Centessa Pharmaceuticals plc (CNTA) | Chief Technology & Quality Ofc | Sell | 8,549 | $210,049 |
| 2026-02-03 | Centessa Pharmaceuticals plc (CNTA) | Chief Technology & Quality Ofc | Buy | 35,000 | $0 |
| 2025-11-18 | Centessa Pharmaceuticals plc (CNTA) | Chief Technology & Quality Ofc | Buy | 40,000 | $376,800 |
| 2025-11-18 | Centessa Pharmaceuticals plc (CNTA) | Chief Technology & Quality Ofc | Sell | 40,000 | $1.1M |
| 2025-11-13 | Centessa Pharmaceuticals plc (CNTA) | Chief Technology & Quality Ofc | Buy | 40,000 | $376,800 |
| 2025-11-13 | Centessa Pharmaceuticals plc (CNTA) | Chief Technology & Quality Ofc | Sell | 40,000 | $1.0M |
| 2025-09-24 | Centessa Pharmaceuticals plc (CNTA) | Chief Technology & Quality Ofc | Buy | 35,000 | $329,700 |
| 2025-09-24 | Centessa Pharmaceuticals plc (CNTA) | Chief Technology & Quality Ofc | Sell | 35,000 | $840,000 |
| 2025-09-11 | Centessa Pharmaceuticals plc (CNTA) | Chief Technology & Quality Ofc | Buy | 24,792 | $198,584 |
| 2025-09-11 | Centessa Pharmaceuticals plc (CNTA) | Chief Technology & Quality Ofc | Sell | 24,792 | $495,840 |
| 2025-09-11 | Centessa Pharmaceuticals plc (CNTA) | Chief Technology & Quality Ofc | Buy | 25,000 | $235,500 |
| 2025-09-11 | Centessa Pharmaceuticals plc (CNTA) | Chief Technology & Quality Ofc | Sell | 25,000 | $550,000 |
| 2025-02-04 | Centessa Pharmaceuticals plc (CNTA) | Chief Technology & Quality Ofc | Sell | 8,693 | $147,086 |
| 2025-02-04 | Centessa Pharmaceuticals plc (CNTA) | Chief Technology & Quality Ofc | Sell | 11,000 | $185,460 |
Source: SEC Form 4 filings · as of 2026-06-24